{
  "metadata": {
    "url": "https://gtejaswini61.blogspot.com/2021/09/a-53-yrs-old-male-patient-with-sob.html",
    "datetime": "2021-09-07T02:49:00-0700"
  },
  "timeline": [
    {
      "ordinal": 1,
      "time": "45 minutes prior to admission",
      "activity": "shortness of breath",
      "symptom": "shortness of breath, cough with blood-tinged sputum",
      "diagnosis": "",
      "treatment": "",
      "notes": {
        "demographics": "53-year-old male, cycle repairer",
        "physical_exam": "",
        "investigations": "",
        "lab_measurements": "",
        "discussion": "patient presented with shortness of breath and cough with blood-tinged sputum"
      }
    },
    {
      "ordinal": 2,
      "time": "admission",
      "activity": "admission to ICU",
      "symptom": "shortness of breath, cough with blood-tinged sputum, pedal edema",
      "diagnosis": "cardiogenic shock secondary to HFrEF with TYPE 1 Respiratory failure",
      "treatment": "intubation, vasopressors (noradrenaline, dobutamine)",
      "notes": {
        "demographics": "",
        "physical_exam": "Spo2: 56%, BP: not recordable, PR: 130/min",
        "investigations": "Chest X-ray, ECG",
        "lab_measurements": "Hb: 13.9, TLC: 17700, RBC: 4.91, PLT: 1.16",
        "discussion": "patient diagnosed with cardiogenic shock secondary to HFrEF with TYPE 1 Respiratory failure"
      }
    },
    {
      "ordinal": 3,
      "time": "Day 2 of admission",
      "activity": "pleural tap",
      "symptom": "cough, shortness of breath",
      "diagnosis": "cardiogenic shock secondary to HFrEF with TYPE 1 Respiratory failure",
      "treatment": "INJ PIPTAZ 4.5 mg/IV/STAT, INJ PANTOP 40mg/IV/OD, INJ NORAD-DS 10 ml/hr",
      "notes": {
        "demographics": "",
        "physical_exam": "Temp: 98.7F, BP: 90/70mmHg, PR: 110bpm",
        "investigations": "",
        "lab_measurements": "",
        "discussion": "patient subjectively feeling better, but still requiring vasopressors"
      }
    },
    {
      "ordinal": 4,
      "time": "Day 3 of admission",
      "activity": "ongoing treatment",
      "symptom": "cough, shortness of breath",
      "diagnosis": "cardiogenic shock secondary to HFrEF with TYPE 1 Respiratory failure",
      "treatment": "INJ PIPTAZ 4.5 mg/IV/TID, INJ PANTOP 40mg/IV/OD, INJ NORAD-DS 20 ml/hr",
      "notes": {
        "demographics": "",
        "physical_exam": "Temp: 98.7F, BP: 90/70mmHg, PR: 140bpm",
        "investigations": "",
        "lab_measurements": "",
        "discussion": "patient still requiring vasopressors, but showing some improvement"
      }
    },
    {
      "ordinal": 5,
      "time": "Day 4 of admission",
      "activity": "ongoing treatment",
      "symptom": "shortness of breath, pedal edema",
      "diagnosis": "cardiogenic shock secondary to HFrEF with TYPE 1 Respiratory failure",
      "treatment": "INJ PIPTAZ 4.5 mg/IV/TID, INJ PANTOP 40mg/IV/OD, INJ NORAD-DS 22 ml/hr",
      "notes": {
        "demographics": "",
        "physical_exam": "Temp: 98.7F, BP: 90/70mmHg, PR: 111bpm",
        "investigations": "",
        "lab_measurements": "",
        "discussion": "patient still requiring vasopressors, but showing some improvement"
      }
    },
    {
      "ordinal": 6,
      "time": "Day 5 of admission",
      "activity": "ongoing treatment",
      "symptom": "shortness of breath, pedal edema",
      "diagnosis": "cardiogenic shock secondary to HFrEF with TYPE 1 Respiratory failure",
      "treatment": "INJ PIPTAZ 4.5 mg/IV/BD, INJ PANTOP 40mg/IV/OD, INJ NORAD-DS 22 ml/hr",
      "notes": {
        "demographics": "",
        "physical_exam": "Temp: 98.7F, BP: 90/70mmHg, PR: 111bpm",
        "investigations": "",
        "lab_measurements": "",
        "discussion": "patient still requiring vasopressors, but showing some improvement"
      }
    },
    {
      "ordinal": 7,
      "time": "12/9/21 @ 1:30 am",
      "activity": "cardiac arrest",
      "symptom": "cardiac arrest",
      "diagnosis": "sudden cardiac arrest secondary to cardiogenic shock",
      "treatment": "CPR according to ACLS guidelines",
      "notes": {
        "demographics": "",
        "physical_exam": "",
        "investigations": "",
        "lab_measurements": "",
        "discussion": "patient suffered cardiac arrest and could not be revived"
      }
    }
  ],
  "imageurl": [
    "https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEijjGx1YPihQexRpMNMNPR5dqFvKzn61kqfR0ji8-wyffaFSSoQE5f2V_ATuTOWSoKQAP8CFzfvtaLLTOz263Rg9Mt6riNXo_d9GxP47O3OX4drSJGsVxCLAbkTs-njpypQXZinM_VUpJU/",
    "https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEguUHzFbf3tl1ginPkFDupiCIHoYhInSsetMa1JZBUhQKYGq27yGVuPekQOhL85ACri4aEMY85h_-IT1IYs3kjctWO7EQXxz4ElE3CudKKl5eWpyxHGke2dhujvMKhw5aoo3GOOJgw8VRA/",
    "https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjYziB9AiKLX2XicNju-eMFniMJr6Fft86x_KZTSbZ3gcR2GwGxb2UdpP2WQDv5ziKqvbrpa8S-hHv82aBBOiisGjE4tunXqOAcGNbC5VTRscNJ8oUrdRrl8Ldd46jnKA617Z8MfI0kbGc/",
    "https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhGety_3PGSVgfAVrL0u8ODXGkAzM2Zv9bU7-hoWJwDiQPzSG8bqKa1QOWHWeI0c5VxKJr_NCw8dAI-ar0bdIu6AT-ON1J715c5Qvkw1u8kbDDhyYyhu7nWI7DlA1pG2v4IYxqS76JHphU/",
    "https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhzM7qLkaAwM0OCMHsZhYSgFnvIoGUiu7TcNjmMPx-ckGv6-U2GoIUTloKaf8W8EkNWbJStSG0AR-83hl6DuKKlMtRAoU1SMA-HD9JbqRonxr7WpifsdJx_unCwTdGgu0Jv5Sl84GWMxkQ/",
    "https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg8-wHAkWauFk6NiKVTPwF-bhxFW_kxrvo237VmOZb5y39usT0_ox4narADfZ86ejoAaRInfq4tVJKy_XUWA2B1m1AlvEaFFGK0A9VK_wugV5tRQCUKvqEYKt1Kp_igMGdPBoutktESC7A/",
    "https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiHF9mY77LU9PdCjjb1TqxeNkAi_4s-AG4_AFtFl3SR0u_jEb47ahUOe-RKbN_5apROLopSKIcScgi93SICMfzh_61pUuuIY9GGRTZLHkYT75rvuVw6aQibzPLirdssjDoRtsDh4IvYfOs/",
    "https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgjs6mfb-WAuDk1BySpTHSLTaIh1SXWE_k5_ozOcDUz_pP4CKDQmd3WtivIsb_KcjOYSgzwkRipsc8Cpjv8DcLZmjHzoZvNXsvxy4tmXxPw12ZyXSGTMhyd1J5Lm0g5XYHgbKz2xgFbZsU/",
    "https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEimhrVuWY9aspzthz3X8GIdBJf92b2RsSfAyfJIDO2JUxum4BpPdRQZHHX_fuqbpgxJAacPvpXvaSEJToPKu9bIhOaEFWLBBn4Zdj13Ipml_p7F7KFm9QxD7x8xYZZESRfvmh6VTyVBzZ8/",
    "https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjqBrQNCTChXJMaF8inrUVGls-_iwmZA6U8aFcQkjvF2YV2FmBxmUp0HbcjBWsC9jjU4lP_g8sDTkUQE2agXmyRWIP2mLabYoPZ6ayrV6yKNHtWby2lfn4rA4xbibE9oUbMCGHQg7bMNng/",
    "https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEixkvsLZOTnfLJ48Ck9fLLrh4k3LWsXrJt-Ot3QA14ZE6h12DcAEbdCZdVj1IRMSAVVz8TvAtUWaN6WfdNF0tOaR1t3roOOMtlsfzfEK_c6S7lyrvpl15dSGoinua7Pg4uIlAI8O3eCMWY/",
    "https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjPkq886a81U71cYWUw2Zd81KZtN0xrQq-Al67fnxobqGBi54rE4NJj11RvqN0nzf9H3uq15vpf2z_4sCBlCcMli_2Rp5vdDOHvPESMviiPjL85HL5UGoWhTLsZzHb4H0GxxGcYGNPvg0c/",
    "https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg6TcylZEe_V0_CIOIeiIWJXykt_BP33Xf0rS45PqfrLLXqYC0KiWzMCQav0yI9RM_EAYE15NqdsqCSAa_W8ClOsZkApR7FCKEhehDVeDkyXv2vKANRtC4r54XSlQjdCWepqzS0a0BEJok/",
    "https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjPzv7CQ6arAZEhMwEwxLzXuzRslvaxCRsiIl8qPrUx-OfTzPwmpkgKG15pzhtxsvbyC9_lvPrSpZiWBlr2jDcTKqFRoZ8m65vJE72Ti5xP-vdIuZXYNJW4uoKSbw1Zsb8mPZ-dflTrSkA/",
    "https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjtE9rY36zW2NNXihjD4tH6n-8jr5prgVl3rkIrjiAUrgLjOZ8fVvM65i1G_c53XiV5VKqMg1h32uLDkDTS906kj75ASRx7fY8nQ_T9x-vHHbeqsiuxhf6BqKgoAOviRzSAbK65g3GD6ik/",
    "https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiB-c15F8LAICnjWcz0-maxmeFRSJgab_gQ2UEnYYs_wv0FacP6f0iMGS_1BinADpemO34mnzGa9nuhIeZoTCCW_Q7BifdEOrmsD8In-0yrRzHqDpfSEcuvk7VCUMrmKv0mIezmnSMZaCk/s320/IMG-20210928-WA0064.jpg"
  ]
}